GLP-1 progress slowed down? Make the next conversation count

A slower week does not tell the whole story.

Weight-management treatment is assessed over time and in the context of your health. A short stretch without a lower scale reading cannot, on its own, tell you whether a medication has stopped helping. NIDDK describes weight-management medication as part of a longer-term plan with nutrition, activity and reassessment when a treatment is not meeting its goals. NIDDK’s care overview.

Five things to bring to your next clinical check-in

1. The trend you are seeing. Bring dates and observations rather than judging the plan from one weigh-in. Include the goals you and your clinician agreed on.
2. The treatment you are actually using. Share the exact preparation, prescribed dose, time at that dose and any missed doses. Include changes in pharmacy or formulation.
3. How the medication fits your day. Explain appetite changes, nausea, constipation, difficulty eating or drinking, and anything affecting your routine.
4. The support around treatment. Discuss meals, activity, sleep, stress and whether you need help from a registered dietitian or another professional.
5. What you want to improve. Your questions might concern weight, strength, energy, tolerability or whether continuing the current plan makes sense.

Should I increase the dose or add another peptide?

Do not treat a plateau as an instruction to do either. Your clinician can reassess the medication, dose, tolerability and goals. Adding treatments without that review makes it harder to understand benefits, side effects and interactions. FDA has raised concerns about compounded GLP-1 dosing beyond approved-label schedules and about dosing errors. Follow the directions for your own prescription. FDA’s safety information.

Keep strength in the conversation.

The joint GLP-1 nutrition advisory emphasizes adequate nutrition and resistance exercise during weight loss. Protein intake alone is not a substitute for strength training. The right approach depends on your health and ability, so discuss a practical plan rather than chasing an extreme calorie target. Read the advisory.

Want to get back into a routine? Our guide to returning to exercise after weight loss covers the questions to bring to your care team. A trainer can help with appropriate exercise; medication changes belong with your prescriber.

What happens if I stop treatment?

Make that decision with a maintenance plan. In the exploratory STEP 1 extension, participants followed after stopping semaglutide 2.4 mg and the trial’s lifestyle intervention regained about two-thirds of their prior weight loss over the next year on average. That finding describes the study group, not a prediction for you or for AnthologyRX’s compounded products. Read the study.

Ask what follow-up, nutrition, activity and other treatment options make sense if cost, side effects or your goals change. Our cost guide can help you prepare for the financial part of that conversation.

When the next step should be medical help

Severe or persistent symptoms deserve medical attention, not another dose experiment. If you have severe abdominal pain, repeated vomiting, difficulty staying hydrated or a serious allergic reaction, seek prompt medical help; call 911 for an emergency. Contact your prescribing clinician for non-emergency questions about symptoms or treatment changes.

Get a plan you can understand.

AnthologyRX connects you with an independent licensed clinician for an individual assessment. Compounded care is considered when it meets an individual medical need; approval, a dose increase or a particular outcome is not automatic. Explore the available formulations, pharmacy information and full plan costs before starting.